Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Identify situations where TRI provides a fuller view of performance than a price index, especially when dividends and compounding matter to total returns.
26,863 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
The U.S.-led airstrike on Iran sent markets into a tailspin, with oil surging and stock indexes dropping. As policyma...
As the EV race heats up in 2026, investors are weighing which rivals to buy. This guide breaks down the top contender...
Pi Network's PI token gained momentum ahead of the Miami appearance of its co-founders, signaling renewed investor in...
Tensions near the Strait of Hormuz are sparking ripples across energy markets and corporate budgets. This crisis is f...
Investors are watching the CLARITY Act as the Senate considers the bill this week. Traders say crypto markets massive...
Oil prices push higher as supply fears mount, triggering a broad debt selloff and jittery stock futures. Iran tension...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...
Oil prices decline as investors weigh possible progress toward a Middle East peace agreement. Markets respond to dipl...
As state treasury bills expand into Bitcoin, traders weigh the potential for sustained demand against a capped supply...
A sweeping crypto downturn sparks roughly $1.2 billion in liquidations, as Ethereum tests key support under $1.7K and...
As 2026 unfolds, three robotics stocks stand out in the M&A spotlight, driven by cash flow, autonomous tech stacks, a...